A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation
Astellas Pharma Inc
Astellas Pharma Inc
Technische Universität Dresden
SWOG Cancer Research Network
Children's Oncology Group
Children's Oncology Group
M.D. Anderson Cancer Center
Canadian Cancer Trials Group
Pfizer
M.D. Anderson Cancer Center
Ludwig-Maximilians - University of Munich
University of Ulm
Memorial Sloan Kettering Cancer Center
SWOG Cancer Research Network
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
St. Jude Children's Research Hospital
European Organisation for Research and Treatment of Cancer - EORTC
Pfizer
Sanofi
European Organisation for Research and Treatment of Cancer - EORTC
Swiss Cancer Institute
Acute Leukemia French Association